SCHEMBL21591486

SCHEMBL21591486

Cc1ccc2c(c1C)OC=C(CN(CCCn1ccnn1)Cc1ccncc1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21592244 0.71 SMN1; SMN2 (0.33) —
SCHEMBL21591499 0.62 CYP11B1 (0.51) —
SCHEMBL30132324 0.61 KDM4E (0.31) —
SCHEMBL21591514 0.60 CYP11B1 (0.40) —
SCHEMBL930156 0.60 CYP19A1 (0.57) —
SCHEMBL21591470 0.58 CYP1A2 (0.39) —
SCHEMBL10090899 0.56 HTR1A (0.38) —
SCHEMBL21591490 0.56 CYP3A4 (0.52) —
SCHEMBL19688317 0.54 HRH1 (0.52) —
SCHEMBL10851197 0.54 MAPT (0.61) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807264-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2021-04-21 — — EP disclosed
WO-2019238786-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2019-12-19 — — WO disclosed
Send feedback